Skip to main content

Table 1 Relationships between lncRNA AC010761.9 expression (ΔCt value) and patient clinical pathologic factors and serum tumor markers

From: Evaluation of the expression and clinical value of lncRNA AC010761.9 in human gastric adenocarcinoma

Characteristics No. of case (%) Mean ± SD p value
Age
 ≥ 60 70 (54.2) 19.08 ± 2.904 0.162
 < 60 59 (45.8) 18.31 ± 3.309  
Gender
 Male 102 (79.1) 18.66 ± 3.087 0.620
 Female 27 (20.9) 18.99 ± 3.227  
Tumor location
 Upper 35 (28.0) 19.33 ± 3.198 0.621
 Middle 48 (38.4) 18.52 ± 3.062  
 Lower 42 (33.6) 18.68 ± 3.140  
Diameter
 ≥ 4 70 (54.2) 19.28 ± 2.967 0.028
 < 4 59 (45.8) 18.07 ± 3.167  
Differentiation
 Poor 97 (75.2) 18.48 ± 3.096 0.047
 Moderate 30 (23.2) 19.73 ± 2.966  
 Well 2 (1.6) 15.39 ± 1.478  
Invasion
 T1 11 (8.5) 18.08 ± 3.155 0.269
 T2 11 (8.5) 18.76 ± 4.302  
 T3 14 (10.8) 17.36 ± 3.074  
 T4 93 (72.2) 19.01 ± 2.931  
Lymphatic metastasis
 N0 32 (24.8) 18.98 ± 3.274 0.597
 N1–3 97 (75.2) 18.64 ± 3.063  
Venous invasion
 Absent 71 (55) 18.67 ± 3.184 0.808
 Present 58 (45) 18.80 ± 3.037  
Perineural invasion
 Absent 59 (45.7) 18.51 ± 3.243 0.399
 Present 70 (54.3) 18.98 ± 2.946  
CEA
 Normal 109 (84.5) 18.48 ± 2.935 0.037
 High 20 (15.5) 20.05 ± 3.727  
CA19-9
 Normal 113 (87.5) 18.50 ± 2.999 0.026
 High 16 (12.5) 20.34 ± 3.469  
AFP
 Normal 121 (93.8) 18.64 ± 3.082 0.248
 High 8 (6.2) 19.96 ± 3.444  
  1. The italicized values are significant at p < 0.05